Justin Xiang

Founder at Syno Partners LLC

Health Technology

Health Services

Finance

Profile

Justin Xiang is the founder and Chief Investment Officer at Syno Partners LLC, which he founded in 2015.
He is currently a Director at Seaport Diagnostics, Inc. Dr. Xiang was also a Director at LungLife AI, Inc.

Justin Xiang active positions

Companies	Position	Start
Seaport Diagnostics, Inc. Seaport Diagnostics, Inc. BiotechnologyHealth Technology Seaport Diagnostics, Inc. operates as a biotechnology company which develops treatments for genetically inherited diseases. It also offers DNA Tests for consumers across many categories such as nutrition, fitness, behavior tendencies, skincare, and more; provides consumers access to genetic information via mobile application; and manages human cell bank for future testing on regenerative medical therapies. The company was founded by Scott Schaus, Robin Y. Smith and Kate Blanchard on June 30, 2014 and is headquartered in Boston, MA.	Director/Board Member	-
Syno Partners LLC Syno Partners LLC Investment ManagersFinance Syno Partners LLC (Syno Partners) is a venture capital firm founded in 2015 by Justin Xiang and Joseph Weilgus. The firm is headquartered in New York.	Founder	31/12/2014

All active positions of Justin Xiang

Former positions of Justin Xiang

Companies	Position	End
LUNGLIFE AI, INC.	Director/Board Member	30/06/2021

See the detail of Justin Xiang's experience

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Justin Xiang's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	1
LUNGLIFE AI, INC.	Health Services

Private companies	2
Seaport Diagnostics, Inc. Seaport Diagnostics, Inc. BiotechnologyHealth Technology Seaport Diagnostics, Inc. operates as a biotechnology company which develops treatments for genetically inherited diseases. It also offers DNA Tests for consumers across many categories such as nutrition, fitness, behavior tendencies, skincare, and more; provides consumers access to genetic information via mobile application; and manages human cell bank for future testing on regenerative medical therapies. The company was founded by Scott Schaus, Robin Y. Smith and Kate Blanchard on June 30, 2014 and is headquartered in Boston, MA.	Health Technology
Syno Partners LLC Syno Partners LLC Investment ManagersFinance Syno Partners LLC (Syno Partners) is a venture capital firm founded in 2015 by Justin Xiang and Joseph Weilgus. The firm is headquartered in New York.	Finance